^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    MI FOLFOXai

    Company:
    Caris Life Sci
    Type:
    Laboratory Developed Test
    Related tests:
    Details
    Evidence

    News

    over3years
    Clinical validation of a machine-learning derived signature predictive of outcomes from first-line oxaliplatin-based chemotherapy in advanced colorectal cancer. (PubMed, Clin Cancer Res)
    Application of FOLFOXai could lead to improvements of treatment outcomes for patients with mCRC and other cancers since patients predicted to have less benefit from oxaliplatin-containing regimens might benefit from alternative regimens.
    Journal • Clinical
    |
    MI FOLFOXai
    |
    Avastin (bevacizumab) • 5-fluorouracil • oxaliplatin • leucovorin calcium